Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by gojotv!on Jun 13, 2021 8:03pm
117 Views
Post# 33379921

RE:Remember the computer age?

RE:Remember the computer age?

Hahaha, here comes the basher, StockScoutX, with more stories... Which computer companies succeeded? The ones whose products had these qualities...

MICROSOFT, because their software was designed to be useful to as many people as possible (just as Aristotle can detect a range of cancers or our PCR tests can be taken AT HOME with a short telehealth appointment! - especially useful 

DELL because they made their product available online long before there was an Amazon and delivery was rapid and professional....(Ichor, Rexall)

and...

APPLE, because, despite its struggles, it simply had the best platform in computers.. (Aristotle beats out Grail's Galieri test by MILES in both sensitivity and specificity!)

 

Anyone trying to convince you that the stopping of trials of the Sona test has anything to do with StageZero is straight-up LYING.

If anything, it will help, as competition dwindles.

Because the upcoming travel boom will be astounding!

 

As for StockScrote's "what about variants?" bla, bla...

Not our problem!

StageZero didn't develop the test we're offering now, We LICENCED it!

So, we'll just licence the next test.

Because we have the LAB! The lab is the key!

PCR tests look for mRNA markers... That's not cheap or easy science.

But it is the best!

And companies are still looking for the gold standard in Covid testing for their employees...

And by then, Aristotle will have taken off on a nice, big, cash runway.

This stock has a price target of $1.25 for a reason...


StockscoutX wrote: There were so many personal computer companies spring up like mushrooms left and right. Many were listed on the stock market. How many still exist in the stock market today or selling? I let you figure that out for yourself.

As for covid testing. It's the same situation as it was in the computer age. SONA is just the beginning. Mass vaccination will make the number of testing drop. In effect the market share for testing will start to shrink enough to make many producers of tests to close shop. Also, competition amongst covid test producers will become much more cut throat. Therefore, who's next?

Moreover, as new variants or viruses emerge some tests will need to be updated involving new research with new infusion of cash resources or abandonned because of whatever reason.

Furthermore, it's in the best interest of StageZero to see massive growth in sales of Aristotle soon or else the SP will stagenate for years or drop further.

You get the picture.


<< Previous
Bullboard Posts
Next >>